ow-level laser and extracorporeal shockwave in patients with carpal tunnel syndrome

Not Applicable

Recruiting

• Conditions: Carpal tunnel syndrome.; Carpal tunnel syndrome; G56.0

• Registration Number: IRCT20220504054734N1
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 54

Inclusion Criteria

Patients with carpal tunnel syndrome
Age between 20 and 60

Exclusion Criteria

History of fracture and dislocation in wrist and hand complex during the last 3 months
History of surgery in wrist and hand complex during the last 6 months
Cervical radiculopathy and thoracic outlet syndrome
Pregnancy
Receiving coricosteriod injection and physiotherapy treatment during the last 3 months
Neurological and systemic diseases, such as rheumatoid arthritis, Parkinson, Multiple Sclerosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Visual analog scale.;Function. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.;Grip power. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Dynamometer.;Pinch power. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Dynamometer.

Secondary Outcome Measures

Name	Time	Method
Amplitude of median sensory nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Amplitude of median motor nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Latency of median sensory nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Latency of median motor nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Median nerve conduction velocity. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Cross sectional area of median nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Sonography apparatus.